July 6, 2020 / 1:22 PM / a month ago

BRIEF-Dragonfly Therapeutics Announces Research Collaboration With Bristol Myers Squibb

July 6 (Reuters) - Bristol-Myers Squibb Co:

* DRAGONFLY THERAPEUTICS ANNOUNCES NEW RESEARCH COLLABORATION WITH BRISTOL MYERS SQUIBB TO DEVELOP NOVEL THERAPEUTIC CANDIDATES FOR MULTIPLE SCLEROSIS AND NEURO-INFLAMMATION TARGET

* DRAGONFLY THERAPEUTICS - BRISTOL MYERS SQUIBB WILL PAY DRAGONFLY A $55 MILLION UPFRONT PAYMENT

* DRAGONFLY THERAPEUTICS - CO WILL GRANT BRISTOL MYERS OPTION TO LICENSE EXCLUSIVE WORLDWIDE INTELLECTUAL PROPERTY RIGHTS TO MULTIPLE CANDIDATES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below